CIK 0001819253 · Accelerated filer<br>Smaller reporting company<br>Emerging growth company
biote Corp.
Sign in to watch- Ticker
- BTMD
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851791125
- Phone
- 972-486-9346
- Business address
- 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
- Former names
- Haymaker Acquisition Corp. III
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy 10% owner bought 74,440 shares at an average $3.19 ($237,406)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4/A Open-market buy 10% owner bought 856,609 shares at an average $3.25 ($2,784,419)
- 4 Open-market buy 10% owner bought 106,000 shares at $3.32 ($351,920)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 75,000 shares at an average $3.95 ($296,043)
- 4 Open-market buy Chief Executive Officer bought 37,595 shares at $3.87 ($145,493)
- 4 Open-market buy Director bought 38,104 shares at $3.88 ($147,844)
- 4 Open-market buy Director bought 107,794 shares at $3.87 ($417,163)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 856,609 shares at an average $3.25 ($2,784,419)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 4 of 21 · 412 filings